Vulnerability of mouse cortical neurons to doxorubicin-induced apoptosis is strain-dependent and is correlated with mRNAs encoding Fas, Fas-Ligand, and metalloproteinases

Apoptosis

Volumn 9, Issue 5, 2004, Pages 649-656

  Wetzel, M ^a   Tibbitts, J ^a   Rosenberg, G A ^a   Cunningham, L A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

C57BL 10; C57BL 6; death receptors; doxorubicin; metalloproteinases; neuronal apoptosis; tissue inhibitor of metalloproteinases

Indexed keywords

DOXORUBICIN; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN CORTEX; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IN VIVO STUDY; INBRED STRAIN; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TISSUE CULTURE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; CEREBRAL CORTEX; DOXORUBICIN; FAS LIGAND PROTEIN; FLOW CYTOMETRY; MEMBRANE GLYCOPROTEINS; METALLOPROTEASES; MICE; MICE, INBRED C57BL; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIES SPECIFICITY;

ANIMALIA;

EID: 4344610515     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:APPT.0000038038.42809.e2     Document Type: Article

References (22)

1. Raoul C, Pettmann B, Henderson CE. Active killing of neurons during development and following stress: A role for p75(NTR) and Fas? Curr Opin Neurobiol 2000; 10(1): 111-117.
2. Qiu J, Whalen MJ, Lowenstein P, et al. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J Neurosci 2002; 22(9): 3504-3511.
3. Morishima Y, Gotoh Y, Zieg J, et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 2001; 21(19): 7551-7560.
4. Rosenbaum DM, Gupta G, D'Amore J, et al. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J Neurosci Res 2000; 61(6): 686-692.
5. D'Souza SD, Bonetti B, Balasingam V, et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996; 184(6): 2361-2370.
6. Wallach D, Kovalenko AV, Varfolomeev EE, Boldin MP. Death-inducing functions of ligands of the tumor necrosis factor family: A Sanhedrin verdict. Curr Opin Immunol 1998; 10(3): 279-288.
7. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999; 9(24): 1441-1447.
8. Mitsiades N, Yu WH, Poulaki V, Tsokos M, Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 2001; 61(2): 577-581.
9. Matsuno H, Yudoh K, Watanabe Y, Nakazawa F, Aono H, Kimura T. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J Rheumatol 2001; 28(1): 22-28.
10. Ethell DW, Kinloch R, Green DR. Metalloproteinase shedding of Fas ligand regulates beta-amyloid neurotoxicity. Curr Biol 2002; 12(18): 1595-1600.
11. Wetzel M, Rosenberg GA, Cunningham LA. Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neurosci 2003; 18(5): 1050-1060.
12. Shuttleworth CW, Connor JA. Strain-dependent differences in calcium signaling predict excitotoxicity in murine hippocampal neurons. J Neurosci 2001; 21(12): 4225-4236.
13. Steward O, Schauwecker PE, Guth L, et al. Genetic approaches to neurotrauma research: Opportunities and potential pitfalls of murine models. Exp Neurol 1999; 157(1): 19-42.
14. Schauwecker PE. Modulation of cell death by mouse genotype: Differential vulnerability to excitatory amino acid-induced lesions. Exp Neurol 2002; 178(2): 219-235.
15. Hertz E, Yu ACH, Hertz L, Juurlink BHJ, Schousboe A. Preparation of Primary Cultures of Mouse Cortical Neurons. In: Shahar A, de Vellis J, Vernadakis A, Haber B, eds. A Dissection and Tissue Culture Manual of the Nervous System Wiley-Liss, New York, 1993; 183-186.
16. Southgate T, Kingston P, Castro M. Gene transfer into neural cells in vitro using adenoviral vectors. In: Current Protocols in Neuroscience. John Wiley and Sons, Inc. 2000: 13(Suppl): 4.23.1-4.23.40.
17. Wallace J, Alexander S, Estrada EY, Hines C, Cunningham L, Rosenberg GA. Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) is associated with neuronal death in reperfusion injury. J Cere Blood Flow Meta 2002; 22(11): 1303-1310.
18. Terrazzino S, Bauleo A, Baldan A, Leon A. Peripheral LPS administrations up-regulate Fas and FasL on brain microglial cells: A brain protective or pathogenic event? J Neuroimmunol 2002; 124(1/2): 45-53.
19. Ahonen M, Poukkula M, Baker AH, et al. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 2003; 22(14): 2121-2134.
20. Kayagaki N, Kawasaki A, Ebata T, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182(6): 1777-1783.
21. Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998; 4(1): 31-36.
22. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001; 2(7): 502-511.